960155-98-0Relevant articles and documents
Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel
Liu, Fengxi,Feng, Lixia,Zhang, Li,Zhang, Xu,Zhang, Na
, p. 41 - 49 (2013)
The purpose of this study is to synthesis and evaluate the antitumor efficacy of a novel carboxymethyl chitosan-docetaxel (CMCS-DTX) conjugates and the availability of CMCS as the polymer material in polymer-drug conjugates development. Docetaxel (DTX) wa
Synthetic copolymer conjugates of docetaxel and: In vitro assessment of anticancer efficacy
Boyer, Cyrille A.,Clemons, Tristan D.,Edwards, Sky,Evans, Cameron W.,Iyer, K. Swaminathan,Kretzmann, Jessica A.,Nealon, Gareth L.,Norret, Marck,Singh, Ruhani
supporting information, p. 20013 - 20020 (2020/12/21)
Docetaxel (DTX) is a widely used chemotherapy drug that is associated with numerous side effects and limited bioavailability. Macromolecular conjugates of DTX may improve drug targeting, solubility, reduce off-target toxicity, and overcome mechanisms of m
Micro-molecule modified taxane water soluble prodrug and pharmaceutical applications thereof
-
Paragraph 0034; 0035; 0036, (2019/03/26)
The invention belongs to the field of biomedicine, and relates to a micro-molecule modified taxane water soluble prodrug and pharmaceutical applications thereof. The invention provides a micro-molecule modified taxane water soluble prodrug represented by
Anti-tumor medicine conjugate, preparation method, preparation and application
-
Paragraph 0070; 0071; 0072; 0073; 0074; 0075, (2017/06/10)
The invention discloses an anti-tumor medicine conjugate, a preparation method, nano-micelle preparation thereof and application. The structural formula of the conjugate provided by the invention is represented by the formula (I), and the conjugate is for
